https://www.nrgtherapeutics.com/wp-content/uploads/2026/08/chronic-neurodegenerative-disorders.jpg450750Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2022-06-24 08:00:052026-09-10 10:29:34NRG Therapeutics to develop small molecule disease-modifying medicines for debilitating chronic neurodegenerative disorders
https://www.nrgtherapeutics.com/wp-content/uploads/2026/08/Change-Jars.jpg461700Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2022-06-01 08:00:202026-08-14 16:27:17£2.68M Award to NRG Therapeutics Supports Work Into Potential DMT
https://www.nrgtherapeutics.com/wp-content/uploads/2026/08/shutterstock_664712080.jpg6831024Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2022-05-31 08:00:272026-08-14 16:28:13Award to help NRG Therapeutics develop new Parkinson’s and Motor Neurone Disease treatments
https://www.nrgtherapeutics.com/wp-content/uploads/2026/08/methode_sundaytimes.jpg450800Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2022-05-29 08:00:262026-09-09 17:41:02Sticking plaster for brain could beat Parkinson’s disease
https://www.nrgtherapeutics.com/wp-content/uploads/2026/08/neil_miller_nrg_therapeutics_0.jpg400605Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2021-08-23 08:00:442026-09-10 10:28:37Parkinson’s UK takes investment in NRG Therapeutics to £2.5m
https://www.nrgtherapeutics.com/wp-content/uploads/2026/08/cambridgeinde-logo.jpg7451238Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2021-08-04 08:00:472026-08-14 16:35:52Cambridge neuroscience specialist NRG Therapeutics secures $500,000 from The Michael J Fox Foundation for Parkinson’s Research
https://www.nrgtherapeutics.com/wp-content/uploads/2026/08/Business-Weekly-logo-300x135-1.jpg310524Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2021-07-29 08:00:052026-09-10 10:28:46NRG Therapeutics wins $500K from Michael J. Fox Foundation for Parkinson’s programme
NRG Therapeutics to develop small molecule disease-modifying medicines for debilitating chronic neurodegenerative disorders
Drug Target Review
£2.68M Award to NRG Therapeutics Supports Work Into Potential DMT
Parkinson’s News Today
Read more
Award to help NRG Therapeutics develop new Parkinson’s and Motor Neurone Disease treatments
Labiotech
Read more
NRG receives £2.68m funding boost for neurodegenerative disorders
Pharma Times
Read more
Sticking plaster for brain could beat Parkinson’s disease
Sunday Times
Read more
(behind a paywall)
NRG Therapeutics awarded £2.68m to fight Parkinson’s and MND
Business Weekly
Read more
Parkinson’s UK takes investment in NRG Therapeutics to £2.5m
Business Weekly
Cambridge neuroscience specialist NRG Therapeutics secures $500,000 from The Michael J Fox Foundation for Parkinson’s Research
Cambridge Independent
Read more
NRG Therapeutics wins $500K from Michael J. Fox Foundation for Parkinson’s programme
Business Weekly